renal cell carcinoma

You have access
Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma
Tingting Chen, Liu Liu, Yonghong Zou, Xiaoyan Hu, Wenfeng Zhang, Tao Zhou, Xi Luo, Weihua Fu and Jie Xu

Cancer Biology & Medicine February 2021, 18 (1) 227-244; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0186
You have access
Current Status of Studies on Targeted Therapy for Renal Cell Carcinoma
Shaoqi Wang, Shaoxiang Wang and Juan Wang

Chinese Journal of Clinical Oncology August 2008, 5 (4) 294-298; DOI: https://doi.org/10.1007/s11805-008-0294-x
You have access
Multilocular Cystic Renal Cell Carcinoma: A Series of 8 Cases and Review of the Literature
Shuo Liu, Guang Sun, Zhanjun Guo and Xiaodong Li

Chinese Journal of Clinical Oncology April 2007, 4 (2) 133-136; DOI: https://doi.org/10.1007/s11805-007-0133-5
You have access
Attenuation of Telomerase Activity by siRNA Targeted Telomerase RNA Leads to Apoptosis and Inhibition of Proliferation in Human Renal Carcinoma Cells
Rumin Wen, Junjie Liu, Wang Li, Wenfa Yang, Lijun Mao and Junnian Zheng

Chinese Journal of Clinical Oncology October 2006, 3 (5) 326-331;
You have access
Correlation between Dynamic Spiral-CT Enhancement Parameters and Tumor Angiogenesis in Renal Cell Carcinomas
Jinhong Wang, Weixia Chen, Xiuhui Zhang, Pengqiu Min, Rongbo Liu and Hengxuan Yang

Chinese Journal of Clinical Oncology June 2005, 2 (3) 615-621;
You have access
Effects of ¹²⁵I-Labeled Peptide Nuclear Acid Targeting Ki67 on the Growth of Implanted Human Renal Cell Carcinoma in Nude Mice
Jiacun Chen, Junnian Zheng, Song Wu, Haibiao Lai, Xiaoqing Sun and Junjie Liu

Chinese Journal of Clinical Oncology December 2004, 1 (6) 448-453;

Main menu

User menu

Search

renal cell carcinoma

Navigate

More Information

For Authors

Journal Services